SPONSORED CONTENT Note: The Advanced 340B Operations Certificate Program is a separate Apexus offering that is not a part of […]
SPONSORED CONTENT On April 19, 2024—fourteen years after the Congressional deadline—the Health Resources and Services Administration published its final rule […]
SPONSORED CONTENT All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit […]
SPONSORED CONTENT The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program […]
SPONSORED CONTENT Since 2020, select drug manufacturers have begun deploying restrictions or limitations on the sale of their products through […]
SPONSORED CONTENT Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach […]
SPONSORED CONTENT As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to […]
SPONSORED CONTENT Attention 340B Covered Entities: For most covered entities, the 340B program is essential to their organization’s bottom line […]
SPONSORED CONTENT Attention 340B Covered Entities: The 340B drug pricing program is entering an exciting phase of evolution. The SUSTAIN […]
SPONSORED CONTENT Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in […]